RPEL

N/A

Report date: 2025/01/26 17:57:09
NME

Base Information

Drug NameRPEL
Drug Alias NameRPEL
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitorsMicrotubule-associated protein tau inhibitors
TargetsBeta amyloid A4 proteinMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversite du Droit et de la Sante de Lille II
China Registration ClassN/A

Develop Information

Active CompaniesUniversite de Caen Basse-NormandieUniversite du Droit et de la Sante de Lille II
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A